Search

Insun Kang

Examiner (ID: 13166, Phone: (571)272-3724 , Office: P/2193 )

Most Active Art Unit
2193
Art Unit(s)
2198, 2193, 2124
Total Applications
943
Issued Applications
727
Pending Applications
50
Abandoned Applications
188

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17141990 [patent_doc_number] => 20210310002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => CATIONIC COMPOUNDS FOR DELIVERY OF NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 17/270832 [patent_app_country] => US [patent_app_date] => 2019-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30965 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -31 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270832 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/270832
CATIONIC COMPOUNDS FOR DELIVERY OF NUCLEIC ACIDS Aug 29, 2019 Pending
Array ( [id] => 17482577 [patent_doc_number] => 20220090081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => NOVEL DNA APTAMER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/416858 [patent_app_country] => US [patent_app_date] => 2019-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7543 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17416858 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/416858
DNA aptamers for pancreatic cancer detection Aug 7, 2019 Issued
Array ( [id] => 17141996 [patent_doc_number] => 20210310008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => PARN AS A BIOMARKER AND THERAPEUTIC TARGET [patent_app_type] => utility [patent_app_number] => 17/266502 [patent_app_country] => US [patent_app_date] => 2019-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20492 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266502 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/266502
PARN AS A BIOMARKER AND THERAPEUTIC TARGET Aug 6, 2019 Pending
Array ( [id] => 17837732 [patent_doc_number] => 20220275037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => ss-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/627991 [patent_app_country] => US [patent_app_date] => 2019-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14089 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627991 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/627991
ss-AMYLOID CYCLIC RIBONUCLEIC ACID, POLYPEPTIDE, AND APPLICATION THEREOF Jul 18, 2019 Pending
Array ( [id] => 17112178 [patent_doc_number] => 20210292775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-23 [patent_title] => System and Methods for Engineering Bacteria Fit for Eukaryotic mRNA Production, Export, and Translation in a Eukaryotic Host [patent_app_type] => utility [patent_app_number] => 17/257837 [patent_app_country] => US [patent_app_date] => 2019-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17257837 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/257837
System and Methods for Engineering Bacteria Fit for Eukaryotic mRNA Production, Export, and Translation in a Eukaryotic Host Jul 4, 2019 Pending
Array ( [id] => 17830462 [patent_doc_number] => 20220267766 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => RNA INTERFERENCE-INDUCING NUCLEIC ACID INHIBITING NONCANONICAL TARGETS OF MICRO RNA, AND USE FOR SAME [patent_app_type] => utility [patent_app_number] => 17/059736 [patent_app_country] => US [patent_app_date] => 2019-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43073 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059736 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/059736
RNA INTERFERENCE-INDUCING NUCLEIC ACID INHIBITING NONCANONICAL TARGETS OF MICRO RNA, AND USE FOR SAME May 30, 2019 Pending
Array ( [id] => 16977959 [patent_doc_number] => 20210222196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => MODIFIED AAV CONSTRUCTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/054794 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12120 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054794 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/054794
Modified AAV constructs and uses thereof May 14, 2019 Issued
Array ( [id] => 17426820 [patent_doc_number] => 20220054528 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS [patent_app_type] => utility [patent_app_number] => 17/299415 [patent_app_country] => US [patent_app_date] => 2019-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26663 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17299415 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/299415
TREATMENT OF ADULT T CELL LEUKEMIA/LYMPHOMA (ATLL) USING MIR-155 INHIBITORS May 14, 2019 Abandoned
Array ( [id] => 16628993 [patent_doc_number] => 20210047646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-18 [patent_title] => Compositions Comprising Immune System Activators and Method of Using Same [patent_app_type] => utility [patent_app_number] => 17/044195 [patent_app_country] => US [patent_app_date] => 2019-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6687 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044195 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044195
Compositions Comprising Immune System Activators and Method of Using Same Apr 8, 2019 Pending
Array ( [id] => 16581482 [patent_doc_number] => 20210015884 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/040029 [patent_app_country] => US [patent_app_date] => 2019-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11337 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040029 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/040029
MODIFIED OLIGONUCLEOTIDES AND METHODS OF USE Mar 20, 2019 Abandoned
Array ( [id] => 17480553 [patent_doc_number] => 20220088057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-24 [patent_title] => THERAPEUTIC AGENT FOR FIBROSIS [patent_app_type] => utility [patent_app_number] => 17/424004 [patent_app_country] => US [patent_app_date] => 2019-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12579 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424004 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/424004
THERAPEUTIC AGENT FOR FIBROSIS Jan 24, 2019 Abandoned
Menu